KOVALCHUK, SOFYA
 Distribuzione geografica
Continente #
NA - Nord America 2.500
EU - Europa 1.637
AS - Asia 1.036
SA - Sud America 126
AF - Africa 33
OC - Oceania 6
Totale 5.338
Nazione #
US - Stati Uniti d'America 2.469
RU - Federazione Russa 571
IT - Italia 419
SG - Singapore 275
CN - Cina 228
HK - Hong Kong 189
PL - Polonia 174
IE - Irlanda 125
VN - Vietnam 108
BR - Brasile 97
DE - Germania 83
SE - Svezia 73
KR - Corea 66
CH - Svizzera 43
IN - India 42
FI - Finlandia 37
FR - Francia 36
GB - Regno Unito 33
JO - Giordania 22
JP - Giappone 21
CA - Canada 19
BD - Bangladesh 14
ID - Indonesia 13
NL - Olanda 10
ZA - Sudafrica 10
AR - Argentina 9
IQ - Iraq 9
TR - Turchia 9
MA - Marocco 7
MX - Messico 7
AT - Austria 6
AU - Australia 6
CI - Costa d'Avorio 6
EC - Ecuador 6
PK - Pakistan 6
UA - Ucraina 6
UZ - Uzbekistan 6
PH - Filippine 5
VE - Venezuela 5
CO - Colombia 3
EG - Egitto 3
ES - Italia 3
GR - Grecia 3
MY - Malesia 3
TJ - Tagikistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BE - Belgio 2
BY - Bielorussia 2
CL - Cile 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
AL - Albania 1
BJ - Benin 1
BO - Bolivia 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LT - Lituania 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
UY - Uruguay 1
Totale 5.338
Città #
Santa Clara 618
Ashburn 336
Fairfield 181
Singapore 178
Warsaw 170
Hong Kong 158
Dublin 125
Woodbridge 107
Chandler 103
Houston 91
Seattle 89
Cambridge 84
San Jose 84
Milan 72
Beijing 66
Wilmington 61
Ann Arbor 60
Seoul 60
Moscow 43
Munich 42
Bern 40
Florence 37
Hanoi 34
Ho Chi Minh City 32
Rome 31
Altamura 29
Boston 29
Los Angeles 29
Lawrence 28
Shanghai 28
Princeton 27
The Dalles 27
Buffalo 25
New York 25
Mumbai 23
Lauterbourg 21
Dallas 16
Council Bluffs 15
Helsinki 15
Tokyo 15
Hefei 13
Lappeenranta 13
Naples 12
Bologna 10
San Diego 10
São Paulo 10
Dearborn 9
Medford 9
Toronto 9
Turin 9
Clifton 8
Dong Ket 8
Falkenstein 8
Jakarta 8
Johannesburg 8
Kent 8
Paris 8
Boardman 7
Denver 7
London 7
Turku 7
Abidjan 6
Chennai 6
Frankfurt am Main 6
Guangzhou 6
Orem 6
Union City 6
Hải Dương 5
Melbourne 5
Norwalk 5
Nuremberg 5
Pisa 5
Redwood City 5
Secaucus 5
Sesto Fiorentino 5
Tianjin 5
Baghdad 4
Boydton 4
Bremen 4
Canton 4
Curitiba 4
Istanbul 4
Montreal 4
Pune 4
Stockholm 4
Thiene 4
Yubileyny 4
Amman 3
Biên Hòa 3
Brescia 3
Chicago 3
Gangdong-gu 3
Genoa 3
Hounslow 3
Lucca 3
Medellín 3
Mexico City 3
Miami 3
Olgiate Olona 3
Osaka 3
Totale 3.606
Nome #
THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI: A PROSPECTIVE COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) OF 1353 ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA 283
The use of Deauville 5-point score could reduce the risk of false-positive fluorodeoxyglucose-positron emission tomography in the posttherapy evaluation of patients with primary bone lymphomas 268
The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study 267
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 261
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study 260
Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: Interobserver agreement and reproducibility across software platforms 251
RESPONSE ORIENTED MAINTENANCE THERAPY IN ADVANCED FOLLICULAR LYMPHOMA. RESULTS OF THE INTERIM ANALYSIS OF THE FOLL12 TRIAL CONDUCTED BY THE FONDAZIONE ITALIANA LINFOMI 247
DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA (HD): RESULTS OF A PHASE II, PROSPECTIVE STUDY BY FONDAZIONE ITALIANA LINFOMI 218
Safety Profile of Idelalisib in Patients with Refractory Follicular Lymphoma: Interim Analysis of a Noninterventional Study 209
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity 209
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 203
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study 200
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 199
A gene expression-based model to predict metabolic response after two courses of ABVD in Hodgkin Lymphoma patients 198
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 196
CLINICAL CHARACTERISTICS OF PATIENTS WITH NEGATIVE INTERIM-PET AND POSITIVE FINAL PET: DATA FROM THE PROSPECTIVE PET-ORIENTED HD0801 STUDY BY FONDAZIONE ITALIANA LINFOMI (FIL) 193
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 190
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma 189
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 180
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 178
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen 174
Multicenter Long Term Follow-up in Hairy Cell Leukemia Patients Treated with Cladribine: A Thirty-Year Experience 174
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) 172
Long-Term results of the FOLL05 trial comparing R-CVP Versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage symptomatic follicular lymphoma 161
Complete remission with brentuximab vedotin in a case of primary cutaneous gamma-delta T-cell lymphoma relapsed after allogeneic stem cell transplantation 153
Treatment and prognosis of primary pulmonary lymphoma: a long-term follow-up study 141
Totale 5.374
Categoria #
all - tutte 14.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022191 2 13 23 16 6 10 8 11 16 10 23 53
2022/2023556 40 77 38 28 30 94 67 28 66 4 15 69
2023/2024313 8 28 32 10 32 39 24 54 11 34 25 16
2024/20251.652 42 146 88 276 496 264 17 94 78 41 49 61
2025/20261.600 216 192 99 116 204 47 195 74 96 112 44 205
2026/20272 2 0 0 0 0 0 0 0 0 0 0 0
Totale 5.374